Activity Overview
This educational activity is an archive of the live conference held on January 24, 2026.
Target Audience
This educational activity is directed toward medical oncologists and practitioners of oncology subspecialties, along with surgeons, radiologists, general scientists, young investigators, nurses, and pharmacists with an interest in lung cancer. Other health care professionals interested in the treatment of lung cancer are also invited to participate.
Learning Objectives
• Integrate emerging clinical trial evidence regarding the management of patients with lung cancer into personalized treatment plans
• Apply best practices for identifying and mitigating treatment-related adverse effects associated with novel therapies for lung cancer
Anne Chiang, MD, PhD
Associate Professor, Section of Thoracic Oncology
Yale School of Medicine
Associate Cancer Center Director, Clinical Initiatives
Yale Cancer Center
New Haven, CT
David R. Gandara, MD
Professor of Medicine Emeritus
Co-Director, Center for Experimental Therapeutics in Cancer
Senior Advisor to the Director
UC Davis Comprehensive Cancer Center
Adjunct Clinical Professor, Translational and Clinical Research
Program
University of Hawaii Cancer Center
Chief Medical Officer, International Society of Liquid Biopsy
Sacramento, CA
Laura Huppert, MD
Assistant Professor of Medicine
Division of Hematology/Oncology
University of California, San Francisco
San Francisco, CA
Corey J. Langer, MD, FACP
Professor of Medicine
Director, Thoracic Oncology
Abramson Cancer Center
University of Pennsylvania
Philadelphia, PA
Joel W. Neal, MD, PhD
Professor of Medicine, Oncology
Stanford University
Palo Alto, CA
Melvin Palalay, MD
Medical Oncologist
University of Hawai‘i Cancer Center
Honolulu, HI
Christina Speirs, MD, PhD
Radiation Oncologist
Cancer Center of Hawaii
Pacific Radiation Oncology
Honolulu, HI
Nicolas Villanueva, MD
Assistant Clinical Professor
Department of Medicine
John A. Burns School of Medicine
University of Hawaiʻi at Mānoa
Clinical Faculty
University of Hawai‘i Cancer Center
Hematology/Oncology
Hawaii Oncology, Inc
Honolulu, HI
Ricardo Blanco, MD
Pulmonologist
St Tammany Health System
Covington, LA
Eric Crawley, MD
Pulmonologist
Hawai‘i Pacific Health
Honolulu, HI
Wally Curran, MD, FACR, FASCO
Whitaker Endowed Chief of Piedmont Oncology
Professor Emeritus and Lawrence D. Davis Chair Emeritus of
Radiation Oncology
Georgia Research Alliance Eminent Scholar and Chair Emeritus in
Cancer Research
Winship Cancer Institute of Emory University
Atlanta, GA
Tamie Kerns, DO
Hematologist-Oncologist
Kaiser Permanente
Honolulu, HI
Mark D. Mayeda, MD
Radiation Oncologist
The Queen’s Health Systems
Honolulu, HI
Brian L. Pettiford, MD, MBA, MMM, FACS
Section Head, General Thoracic Surgery
Division of Cardiothoracic Surgery
Department of Surgery
Ochsner Medical Center
New Orleans, LA
Suma Reddy-Satti, MD
Vice Chair, Hematology/Oncology
St Tammany Cancer Center
Medical Oncologist
Ochsner Health
New Orleans, LA
Rebecca Shatsky, MD
Professor of Medicine
Breast Medical Oncology Team Leader
Director of Breast Cancer Clinical Trials
Director of Inflammatory and Triple Negative Breast Cancer Program
University of California, San Diego
San Diego, CA
Jonathan W. Riess, MD, MS
Associate Professor of Medicine
Director, Thoracic Oncology
UC Davis Comprehensive Cancer Center
Sacramento, CA
Michael Roach, MD
Radiation Oncologist
Cancer Center of Hawaii
Honolulu, HI
Ashley Springer, MSN, AGPCNP-BC, APRN-Rx
Assistant Professor
University of Hawaiʻi Cancer Center
University of Hawai‘i at Mānoa
Honolulu, HI
Naoto T. Ueno, MD, PhD
Professor of Medicine
Director, University of Hawaiʻi Cancer Center
John A. Burns School of Medicine
University of Hawaiʻi at Mānoa
Honolulu, HI
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
